RAD001

Informações
Tipo de Projeto: 
Pesquisa
Coordenador: 
Juliana Pereira
Pesquisadores envolvidos: 
Felipe V. R. Maciel, Luis alberto de Pádua Covas Lage, Marcelo Bellesso, Andre Neder Ramires Abdo
Finalizado: 
Sim
Inicio: 
2011
Término: 
2014
Resumo
A randomized, double-blind, placebo-controlled, multicenter phase III study of RAD001 adjuvant therapy in poor risk patients with Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 versus matching placebo after patients have achieved complete response with first-line rituximab-chemotherapy.